Overview

Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer

Status:
Completed
Trial end date:
2017-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to look at how much a new trial drug get into body, such as when the drug concentration in your body reaches peak and how high the peak value is.
Phase:
Phase 1
Details
Lead Sponsor:
Ferring Pharmaceuticals